- Home
- ENTX vs KULR Comparison
ENTX vs KULR Comparison
Compare ENTX & KULR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENTX | KULR |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.0M | 163.0M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ENTX | KULR |
|---|---|---|
| Price | $1.71 | $3.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $10.00 | ★ $40.00 |
| AVG Volume (30 Days) | 219.0K | ★ 1.6M |
| Earning Date | 11-14-2025 | 11-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $124,000.00 | ★ $16,677,036.00 |
| Revenue This Year | N/A | $64.40 |
| Revenue Next Year | N/A | $105.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 25.25 | ★ 71.92 |
| 52 Week Low | $1.50 | $2.15 |
| 52 Week High | $3.22 | $27.52 |
Technical Indicators
Market Signals| Indicator | ENTX | KULR |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 49.95 |
| Support Level | $1.53 | $2.93 |
| Resistance Level | $1.99 | $3.69 |
| Average True Range (ATR) | 0.19 | 0.25 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 32.73 | 44.90 |
Price Performance
Historical ComparisonAbout ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About KULR KULR Technology Group Inc.
KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices.